pfizer news - Search News

Activist Investor Starboard Value Takes $1B Stake in Pfizer

Pfizer CEO plans to meet activist investor Starboard Value, FT reports

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing people familiar with the matter.

Hosted on MSN · 1h

Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer

Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro

BioSpace · 8h

Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its COVID-19 products.

Pfizer, GSK

Reuters on MSN · 7h

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's High Court. Pfizer and BioNTech had filed their lawsuit in September 2022 over patents relating to messenger RNA (mRNA) technology,

AOL · 1d

Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated

Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion in Pfizer as the pharmaceutical giant grapples with a downturn in demand for COVID-19 vaccines and treatments.

Seeking Alpha · 1d

U.K. court rules in Pfizer's favor in GSK RSV vaccine dispute: report

Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine. Read more here.

Pfizer, Arcadium Lithium, Richemont

The Motley Fool · 1d

Why Pfizer Stock Popped on Monday

How Pfizer got itself in a pickle. As the Journal explains, Pfizer bet big on vaccines to protect people from COVID, but as the pandemic waned, so did interest in (and sales of) i

Wall Street Journal · 1d

Stocks to Watch Monday: Pfizer, Arcadium Lithium, Richemont

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the struggling drugmaker to make changes to turn its performance around, [The Wall Street Journal reported](

Barron's on MSN · 1d

These Stocks Are Moving the Most Today: Pfizer, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, Duckhorn, and More

Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Apple and Amazon shares are downgraded, and Rio Tinto approaches Arcadium Lithium about a potential acquisition.

FierceBiotech1h

'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

11h

GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

FiercePharma3h

Pfizer, bracing for Hurricane Milton, pledges aid to emergency services and health support

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

23h

Meet Jeff Smith, the hedge-fund investor taking on Pfizer

Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...

11h

Pfizer: A 6% Yielding Ultra SWAN Bargain With Upside Potential

Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...

Pfizer to Showcase Scientific Advancements in Respiratory and Other Infectious Diseases at IDWeek 2024

Pfizer Inc. (NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2024 congress, held ...

11h

Analysis-GSK, Pfizer RSV Vaccine Sales Fall in US as Millions Fewer People Line Up

(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...

9hon MSN

Pfizer CEO’s Job Is at Risk. A Shot of Discipline Could Help.

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics